Results 121 to 130 of about 1,224 (170)

AI-based patient monitoring for fall prevention in stroke patients: a pilot study at a Malaysian acute stroke unit. [PDF]

J Neuroeng Rehabil
Danial M, Chow CT, Lim MH, Ayop NA, Looi I, Ch'ng ASH.   +5 more
europepmc   +1 more source

Exercise and Autonomic Cardiovascular Function—Insights From Spinal Cord‐Injured Humans: A Narrative Review

Acta Physiologica, Volume 242, Issue 10, October 2026.
ABSTRACT The cardiovascular response to acute exercise is mediated by the autonomic nervous system (ANS) control mechanisms that modulate vascular resistance to support blood pressure and ensure adequate blood flow to active muscles. These autonomic neurocirculatory control mechanisms include a feedforward mechanism, known as central command, and three
Rasmus Kopp Hansen, Ryan Godsk Larsen, Tom E. Nightingale, Daniel D. Hodgkiss, Niels H. Secher, Stefanos Volianitis   +5 more
wiley   +1 more source

Quantitative 3D Evaluation of Facial Soft Tissue Modifications Following Complete Denture Treatment in Edentulous Patients: A Prospective Before-After Study. [PDF]

J Clin Med
Toser I, Veja I, Cândea A, Faur AB, Constantin GD, Anghel-Lorinti AE, Jivănescu A.   +6 more
europepmc   +1 more source

What if Adam Smith Debated an AI Economist: A Thought Experiment on Markets, Ethics, and the Invisible Hand

Business Ethics, the Environment &Responsibility, Volume 35, Issue 4, Page 3433-3447, October 2026.
ABSTRACT Can AI‐driven capitalism sustain the moral preconditions of market order? We stage a dialogue between Adam Smith and a steel‐manned “EconAI” to test four Moral‐Market‐Fitness criteria: trustworthiness, fairness, non‐domination, and contestability, across 11 dilemmas.
Alexandra‐Codruța Bîzoi, Cristian‐Gabriel Bîzoi   +1 more
wiley   +1 more source

In Silico Identification of Natural-Product Aromatase (CYP19A1) Inhibitors via Integrated Molecular Docking and QSAR Modelling. [PDF]

Bioinform Biol Insights
Akanko EA, Kporvie SS, Hanson G, Adu-Manu KS.   +3 more
europepmc   +1 more source

Dualsteric and dual‐acting modulation of muscarinic receptors by antagonist KH‐5

British Journal of Pharmacology, Volume 183, Issue 19, Page 5769-5790, October 2026.
Abstract Background and purpose Muscarinic acetylcholine receptors are key therapeutic targets, and ligands engaging both orthosteric and allosteric sites may offer improved selectivity and efficacy. Here, we investigated whether the muscarinic antagonist KH‐5 acts as a dualsteric antagonist and defined its mode of interaction with muscarinic receptors.
Alena Janoušková‐Randáková, Eva Dolejší, Nikolai Chetverikov, Jan Jakubík   +3 more
wiley   +1 more source

Oral Medications for Treating Agitation in a Safety Net Emergency Department.

JAMA Netw Open
Cole JB, Hurreh KM, Taghizadeh LA, Laudenbach AP, Olives TD, Miner JR, Driver BE.   +6 more
europepmc   +1 more source

Experimental and numerical investigation of the axial compressive behavior of GFRP-reinforced concrete walls under concentric and eccentric loading. [PDF]

Sci Rep
El-Sayed TA, Ibrahim MM, Shanour AS, Mohamed Fahmy YGE.   +3 more
europepmc   +1 more source

Cannabinoid CB1 allosteric ligands suppress inflammatory pain in male mice without tolerance, motor impairment, memory deficits or respiratory depression

British Journal of Pharmacology, Volume 183, Issue 20, Page 6132-6153, October 2026.
Abstract Background and Purpose Positive allosteric modulators (PAMs) engage sites distinct from the orthosteric CB1 cannabinoid receptor binding site. GAT211, a racemic ligand, contains GAT228 (R) and GAT229 (S) enantiomers. Whether enantiomer‐mediated differences in allosteric activation or positive allosteric modulation translate into differences in
Ifeoluwa D. Solomon, Sumanta Garai, Ganesh A. Thakur, Andrea G. Hohmann   +3 more
wiley   +1 more source

Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI). [PDF]

Pigment Cell Melanoma Res
Dalmasso B, Scaini MC, Cendron L, Rodolfo M, Mattavelli I, Tamborini E, Collina F, Ferrara G, Madonna G, Cota C, Melucci E, Tommasi S, Ubaldi M, Depenni R, Carugno A, Marconcini R, Orgiano L, Lombardo M, Sola S, Pellegrini C, Castiglione F, Gasparotto M, Jorkesh A, Pellegrini S, Raposio E, Boutros A, Tanda ET, Guida M, Quaglino P, Palmieri G, Massi D, Ascierto PA, Spagnolo F, Mandalà M, Menin C, Ghiorzo P, Pastorino L, Italian Melanoma Intergroup.   +37 more
europepmc   +1 more source